Scintillation Nanotechnologies


Scintillation Nanotechnologies, Inc. is dedicated to revolutionizing the sensitivity, selectivity, and resolution of chemical and biological assays through constant innovation in nanoscale radioisotope detectors. The company aims to enable breakthrough discoveries in biological, chemical, and environmental systems by providing previously unattainable measurement capabilities, thus expanding humankind’s knowledge for the betterment of the planet and the human condition.

Industries

biopharma
biotechnology
pharmaceutical

Nr. of Employees

small (1-50)

Scintillation Nanotechnologies


Products

aquaSCINT

Aqueous, organic‑solvent‑free scintillation formulation for continuous non‑specific detection of radiolabeled compounds in aqueous samples and live cells.

aquaSCINT‑IC

A variant formulated for incorporation into mammalian cells to enable continuous intracellular, non‑specific radioisotope detection in aqueous environments.

nanoSPA

Nanoparticle scintillators engineered for scintillation proximity assays with configurable surface chemistries (streptavidin, his‑tag, protein A, protein G) and particle properties optimized for dispersibility and suspension stability.

nanoSPA‑LA

A coated variant of the SPA nanoparticle formulation designed to reduce non‑specific adsorption for challenging proximity assays.


Services

Custom orders for alternate optical variants and product configurations available by contacting sales; custom ordering may increase lead time.

Expertise Areas

  • Aqueous radiolabeled compound detection
  • Scintillation proximity assay materials
  • Nanoparticle surface functionalization for bioassays
  • Live‑cell and intracellular radiotracer measurements
  • Show More (3)

Key Technologies

  • Nanoparticle scintillators
  • Scintillation proximity assay (SPA) materials
  • Aqueous, organic‑solvent‑free scintillation detection
  • Silica‑surface nanoparticle functionalization
  • Show More (4)

News & Updates

Tucson-based Scintillation Nanotechnologies, Inc. has been selected to exhibit nanoparticle scintillator platform at SLAS 2022 International Conference and Exhibition, highlighting their next-generation nanoparticles for detection of radiolabeled compounds directly in aqueous samples.

The company was selected to exhibit their nanoparticle scintillator platform at the COMPPÅ Symposium, focusing on membrane protein production and analysis, with the goal of providing researchers with unprecedented insights into drug uptake, binding, and distribution.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.